Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHunting Regulatory News (HTG)

Share Price Information for Hunting (HTG)

Share Price is delayed by 15 minutes
Get Live Data
472.50    6.50 (1.39%)
Bid:
472.50
Ask:
473.00
Spread: 0.50 (0.106%)
Market Cap: £690.41m
HTG Live PriceLast checked at - London Stock Exchange

Intraday Hunting Share Chart

Statement re:Placing

5 Aug 2011 18:16

RNS Number : 8935L
Hunting PLC
05 August 2011
 



THIS DOCUMENT (AND THE INFORMATION CONTAINED HEREIN) IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN

 

These written materials do not contain or constitute an offer of or the solicitation of an offer to buy or subscribe for securities to any person in Australia, Canada, Japan or the United States or in any jurisdiction in which such offer or solicitation is unlawful. The securities referred to herein may not be offered or sold in the United States absent registration under the US Securities Act of 1933, as amended or an exemption from, or in a transaction not subject to, registration. Subject to certain exceptions, the securities referred to herein may not be offered or sold in Australia, Canada or Japan or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada or Japan. The offer and sale of the securities referred to herein has not been and will not be registered under the US Securities Act of 1933, as amended, or under the applicable securities laws of Australia, Canada or Japan. There will be no public offer of the securities in the United States.

 

For Immediate Release

5 August 2011

 

 

Hunting PLC

 

Statement re: Placing

 

Further to the announcements released earlier today regarding the placing of 13,175,838 new ordinary shares at a placing price of 648 pence (the "Placing"), the Company has been informed that Barclays Capital, the investment banking division of Barclays Bank PLC, ("Barclays Capital"), and RBS Hoare Govett Limited ("RBS Hoare Govett") will take up, under the underwriting agreement, approximately 2.3 million shares each and RBS Hoare Govett and Barclays Capital intend to manage their respective positions in an orderly manner. In addition the Placing was taken up by institutional investors, with approximately 8.4 million shares being placed with existing shareholders.

 

Barclays Capital and RBS Hoare Govett are acting as Joint Bookrunners on behalf of Hunting in respect of the Placing.

 

Enquiries

Hunting PLC

+44 (0)20 7321 0123

Peter Rose, Finance Director

Barclays Capital (Joint Broker and Bookrunner)

+44 (0)20 7623 2323

Alisdair Gayne

Bertie Whitehead

David Seal

RBS Hoare Govett (Joint Broker and Bookrunner)

+44 (0) 20 7678 8000

Stephen Bowler

Lee Morton

Max Jones

 

Forward-looking Statements

 

This announcement contains (or may contain) certain forward-looking statements with respect to certain of Hunting's plans and its current goals and expectations relating to its future financial condition and performance and which involve a number of risks and uncertainties. Hunting cautions readers that no forward-looking statement is a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking statements. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as 'aim', 'anticipate', 'target', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', or other words of similar meaning. Examples of forward-looking statements include, among others, statements regarding Hunting's future financial position, income growth, impairment charges, business strategy, projected levels of growth in its markets, projected costs, estimates of capital expenditure, and plans and objectives for future operations of Hunting and other statements that are not historical fact.

 

By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances, including, but not limited to, UK domestic and global economic and business conditions, the effects of continued volatility in credit markets, market-related risks such as changes in interest rates and exchange rates, the policies and actions of governmental and regulatory authorities, changes in legislation, the further development of standards and interpretations under International Financial Reporting Standards ("IFRS") applicable to past, current and future periods, evolving practices with regard to the interpretation and application of standards under IFRS, the outcome of pending and future litigation, the success of future acquisitions and other strategic transactions and the impact of competition - a number of which factors are beyond Hunting's control. As a result, Hunting's actual future results may differ materially from the plans, goals, and expectations set forth in Hunting's forward-looking statements. Any forward-looking statements made herein by or on behalf of Hunting speak only as of the date they are made. Except as required by the FSA, the London Stock Exchange or applicable law, Hunting expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this announcement to reflect any changes in Hunting's expectations with regard thereto or any changes in events, conditions or circumstances on which any such statement is based.

 

This announcement is for information only and shall not constitute an offer to buy, sell, issue, or acquire or the solicitation of an offer to buy, sell or issue, or acquire any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

 

This announcement has been issued by and is the sole responsibility of Hunting. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by the Joint Bookrunners or any of their respective affiliates or agents as to or in relation to, the accuracy or completeness of this announcement or any other written or oral information made available to or publicly available ("Publicly Available Information") to any interested party or its advisers, and any liability therefore is expressly disclaimed.

 

Barclays Capital, which is authorised and regulated by the FSA, is acting exclusively for Hunting and for no one else in connection with the Placing and will not be responsible to anyone other than Hunting for providing the protections afforded to the customers of Barclays Capital or for providing advice in relation to the Placing or in relation to the contents of this announcement or any other transaction, arrangement or matter referred to herein.

 

RBS Hoare Govett, which is authorised and regulated by the FSA, is acting exclusively for Hunting and for no one else in connection with the Placing and will not be responsible to anyone other than Hunting for providing the protections afforded to the customers of RBS Hoare Govett Limited or for providing advice in relation to the Placing or in relation to the contents of this announcement or any other transaction, arrangement or matter referred to herein.

 

The distribution of this announcement and the offering of the Placing Shares in certain jurisdictions may be restricted by law. No action has been taken by Hunting or the Joint Bookrunners that would permit an offering of such shares or possession or distribution of this announcement or any other offering or publicity material relating to such shares in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required by Hunting or the Joint Bookrunners to inform themselves about, and to observe, such restrictions.

 

The price of shares and the income from them may go down as well as up and investors may not get back the full amount invested on disposal of the shares. Past performance is no guide to future performance and persons needing advice should consult an independent financial adviser.

 

These written materials do not contain or constitute an offer of or the solicitation of an offer to buy or subscribe for securities to any person in Australia, Canada, Japan or the United States or in any jurisdiction in which such offer or solicitation is unlawful. The securities referred to herein may not be offered or sold in the United States absent registration under the US Securities Act of 1933, as amended or an exemption from, or in a transaction not subject to, registration. Subject to certain exceptions, the securities referred to herein may not be offered or sold in Australia, Canada or Japan or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada or Japan. The offer and sale of the securities referred to herein has not been and will not be registered under the US Securities Act of 1933, as amended, or under the applicable securities laws of Australia, Canada or Japan. There will be no public offer of the securities in the United States.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUVABRAOAWRAR
Date   Source Headline
30th May 20237:00 amRNSMajor OCTG order & revised 2023 full year guidance
19th May 202312:29 pmRNSDirectors Shareholding/PDMR transactions
16th May 20233:32 pmRNSDirector Shareholding/PDMR
5th May 20237:00 amRNSDirector/PDMR Shareholding
2nd May 202310:05 amRNSTR-1: Notification of major holdings
27th Apr 20233:35 pmRNSPayment of 2022 Final Dividend in Sterling
27th Apr 202312:56 pmRNSDirector Shareholding/PDMR
26th Apr 202311:44 amRNSTR-1: Notification of Major Holdings
20th Apr 20232:36 pmRNSReport on Payments to Govts
19th Apr 202312:54 pmRNSResult of AGM
19th Apr 20237:00 amRNSAGM and Q1 2023 Trading Update
21st Mar 202312:00 pmRNSDirectors Shareholding/PDMR Replacement
16th Mar 20234:00 pmRNSAnnual Report and Accounts 2022 and Notice of AGM
10th Mar 20234:39 pmRNSDirectors Shareholding/PDMR transactions
9th Mar 20233:45 pmRNSDirectors Shareholding/PDMR
9th Mar 20233:39 pmRNSDirectors Shareholding/PDMR
3rd Mar 20237:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Mar 20237:01 amRNSLaunch of 2030 Strategy & Capital Markets Day
2nd Mar 20237:00 amRNSResults for the year ended 31 December 2022
26th Jan 20236:00 pmRNSMicro Focus International
26th Jan 20234:58 pmRNSTR-1: Notification Of Major Holdings
17th Jan 20237:00 amRNSAppointment of Joint Corporate Broker
3rd Jan 20237:00 amRNSAppointment of non-executive Director
15th Dec 20227:00 amRNSYear-End Trading Update
2nd Nov 202211:18 amRNSDirector Shareholding/PDMR
2nd Nov 202211:17 amRNSDirector Shareholding/PDMR
2nd Nov 202211:16 amRNSDirector Shareholding/PDMR
27th Oct 20227:00 amRNSQ3 2022 Trading Update
14th Oct 20224:00 pmRNSPayment of 2022 Interim Dividend in Sterling
5th Oct 20223:44 pmRNSDirector Shareholding/PDMR
29th Sep 20224:14 pmRNSDirector Declaration
12th Sep 202212:42 pmRNSTR-1: Notification Of Major Holdings
6th Sep 202210:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
25th Aug 20227:01 amRNSTrading Update
25th Aug 20227:00 amRNSUnaudited results for the six months to 30/06/22
5th Jul 20221:10 pmRNSPDMR Shareholding
30th Jun 20227:00 amRNSH1 2022 Trading Update
24th Jun 20227:00 amRNSChange of Registered Office
29th Apr 20224:00 pmRNSReport on Payments to Governments
28th Apr 20222:29 pmRNSPayment of 2021 Final Dividend in Sterling
20th Apr 20222:40 pmRNSResults of AGM and Directorate Change
20th Apr 20227:00 amRNSAGM and Q1 2022 Trading Update
5th Apr 20221:29 pmRNSTR-1: Notification of major holdings
28th Mar 20229:34 amRNSHolding(s) in Company
23rd Mar 20222:30 pmRNSDirector Shareholding / PDMR Transactions
17th Mar 20223:00 pmRNS2021 Annual Report and Accounts and Notice of AGM
16th Mar 20229:43 amRNSTR-1: Notification of Major Holdings
7th Mar 20224:00 pmRNSDirector Shareholding/PDMR Transactions
7th Mar 20224:00 pmRNSDirector/PDMR Shareholding
4th Mar 20229:41 amRNSDirectors Shareholding/PDMR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.